These two processes are initially triggered by a diffuse endothelial dysfunction induced by SARS-CoV-2 through ACE-2 receptors and the transmembrane protease serine 2 that are currently recognized as specific sites by which the virus enters into the vascular system. This evidence concerns the gene TMPRSS2 and endothelial dysfunction.